Left Ventricular Assist Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Left Ventricular Assist Devices Pipeline Market Report Overview 

An implantable left ventricular assist device is a ventricular assist system intended for the treatment of end-stage heart failure. It assists the left ventricle by pumping oxygenated blood to the body. It can also be used to treat the right ventricle in some cases.

The left ventricular assist devices pipeline market research report provides comprehensive information about the left ventricular assist devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the report provides information about various pipeline products and their estimated approval dates.

Left Ventricular Assist Devices Pipeline Products Market Segmentation by Territories

Some of the key territories with products in the pipeline are the US, Europe, Japan, China, India, Israel, Canada, Singapore, South Korea, and Taiwan among others. The US is the leading territory in the left ventricular assist devices pipeline products market as of February 2023.

Left Ventricular Assist Devices Pipeline Products Market Analysis by Territories, 2023 (%)

Left Ventricular Assist Devices Pipeline Products Market Analysis by Territories, 2023 (%)

 For more territory insights into the left ventricular assist devices pipeline products market, download a free report sample

Left Ventricular Assist Devices Pipeline Products Market Segmentation by Regulatory Paths

The left ventricular assist devices pipeline report provides detailed insights into the pipeline products by a regulatory path including PMA, CE, Shonin, NMPA, ICAC, MDL, HDE Approvals, HSA, and 510(k) among others. Most of the products follow the PMA pathway to enter the market.

Left Ventricular Assist Devices Pipeline Products Market Analysis by Regulatory Paths, 2023 (%)

Left Ventricular Assist Devices Pipeline Products Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the left ventricular assist devices pipeline products market, download a free report sample

Left Ventricular Assist Devices Pipeline Products Market - Competitive Landscape

Some of the leading companies in the left ventricular assist devices pipeline products market are Abbott Laboratories, Abiomed Inc, APK Advanced Medical Technologies Inc., Arrow International Cr, A.S., BioVentrix Inc, Calon Cardio-Technology Ltd, Cardiac Success Ltd, CardiacBooster BV, CARDIAnove Inc, and Carnegie Mellon University.

Abbott Laboratories: Abbott Laboratories (Abbott) discovers, develops, manufactures, and sells a diversified range of healthcare products including branded generic pharmaceuticals, diagnostic systems & tests, and pediatric & adult nutritional products. The company also offers various medical devices including heart failure, electrophysiology, rhythm management, vascular & structural heart devices, and neuromodulation devices.

Abiomed Inc: Abiomed Inc (Abiomed) is a medical device company that develops, manufactures, and markets circulatory support devices. The devices replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio include Impella heart pumps (catheter-based devices including micro heart pumps, expandable catheter pumps, and axial flow pumps) and Breethe system (implantable cardiac and respiratory assist devices).

For more insights on the leading players in the left ventricular assist devices pipeline products market, download a free report sample

Left Ventricular Assist Devices Pipeline Products Market Report Overview

Key Territories The US, Europe, Japan, China, India, Israel, Canada, Singapore, South Korea, and Taiwan
Key Regulatory Paths PMA, CE, Shonin, NMPA, ICAC, MDL, HDE Approvals, HSA, and 510(k)
Leading Companies Abbott Laboratories, Abiomed Inc, APK Advanced Medical Technologies Inc., Arrow International Cr, A.S., BioVentrix Inc, Calon Cardio-Technology Ltd, Cardiac Success Ltd, CardiacBooster BV, CARDIAnove Inc, and Carnegie Mellon University

Left Ventricular Assist Devices Pipeline Products Territorial Outlook (Number of Products, 2023) 

  • The US
  • Europe
  • Japan
  • China
  • India
  • Israel
  • Canada
  • Singapore
  • South Korea
  • Taiwan 

Left Ventricular Assist Devices Pipeline Products Regulatory Paths Outlook (Number of Products, 2023)

  • PMA
  • CE
  • Shonin
  • NMPA
  • ICAC
  • MDL
  • HDE Approvals
  • HAS
  • 510(k)

Scope

  • Extensive coverage of the left ventricular assist devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of left ventricular assist devices and lists all their pipeline projects
  • The coverage of pipeline products is based on various stages of development ranging from early development to the approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of left ventricular assist devices under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Abbott Laboratories
Abiomed Inc
APK Advanced Medical Technologies, Inc.
Arrow International Cr, A.S.
BioVentrix Inc
Calon Cardio-Technology Ltd
Cardiac Success Ltd
CardiacBooster BV
CARDIAnove Inc
Carnegie Mellon University
Cleveland Clinic Hospital
Cleveland Heart Inc
CorAssist Cardiovascular Ltd
Corvion Inc
CorWave SA
Duke University
Evaheart Inc
FineHeart
HeartWare International Inc
Indian Institute of Technology, Kanpur
Inspired Therapeutics LLC
Jarvik Heart Inc
LaunchPoint Technologies Inc
Leviticus Cardio Ltd
Levram Medical Systems Ltd
Magenta Medical Inc
Mayo Clinic
Medtronic Plc
Nipro Corp
OrbusNeich
Percassist Inc
Perfusion Solution Inc
PlugMed Heart SAS
PulseCath BV
ReliantHeart, Inc.
Shenzhen Core Medical Technology Co Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Sunshine Heart Company, Pty. Ltd.
Syntach AB
Thoratec LLC
Tokyo Medical and Dental University
U.S. Stem Cell Inc
University of Virginia
VASCOR Inc
Windmill Cardiovascular Systems, Inc.
W-Z BIOTECH, LLC
Yale University

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 10

2 Introduction 11

2.1 Left Ventricular Assist Devices Overview 11

3 Products under Development 12

3.1 Left Ventricular Assist Devices – Pipeline Products by Stage of Development 12

3.2 Left Ventricular Assist Devices – Pipeline Products by Territory 13

3.3 Left Ventricular Assist Devices – Pipeline Products by Regulatory Path 14

3.4 Left Ventricular Assist Devices – Pipeline Products by Estimated Approval Date 15

3.5 Left Ventricular Assist Devices – Ongoing Clinical Trials 16

4 Left Ventricular Assist Devices – Pipeline Products under Development by Companies 17

4.1 Left Ventricular Assist Devices Companies – Pipeline Products by Stage of Development 17

4.2 Left Ventricular Assist Devices – Pipeline Products by Stage of Development 19

5 Left Ventricular Assist Devices Companies and Product Overview 21

5.1 Abbott Laboratories Company Overview 21

5.1.1 Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Abiomed Inc Company Overview 22

5.2.1 Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 APK Advanced Medical Technologies, Inc. Company Overview 29

5.3.1 APK Advanced Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

5.4 Arrow International Cr, A.S. Company Overview 30

5.4.1 Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview 30

5.5 BioVentrix Inc Company Overview 31

5.5.1 BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.6 Calon Cardio-Technology Ltd Company Overview 32

5.6.1 Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.7 Cardiac Success Ltd Company Overview 34

5.7.1 Cardiac Success Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.8 CardiacBooster BV Company Overview 35

5.8.1 CardiacBooster BV Pipeline Products & Ongoing Clinical Trials Overview 35

5.9 CARDIAnove Inc Company Overview 36

5.9.1 CARDIAnove Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.10 Carnegie Mellon University Company Overview 37

5.10.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 37

5.11 Cleveland Clinic Hospital Company Overview 38

5.11.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 38

5.12 Cleveland Heart Inc Company Overview 39

5.12.1 Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.13 CorAssist Cardiovascular Ltd Company Overview 40

5.13.1 CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.14 Corvion Inc Company Overview 43

5.14.1 Corvion Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.15 CorWave SA Company Overview 44

5.15.1 CorWave SA Pipeline Products & Ongoing Clinical Trials Overview 44

5.16 Duke University Company Overview 46

5.16.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 46

5.17 Evaheart Inc Company Overview 47

5.17.1 Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.18 FineHeart Company Overview 50

5.18.1 FineHeart Pipeline Products & Ongoing Clinical Trials Overview 50

5.19 HeartWare International Inc Company Overview 51

5.19.1 HeartWare International Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.20 Indian Institute of Technology, Kanpur Company Overview 55

5.20.1 Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview 55

5.21 Inspired Therapeutics LLC Company Overview 56

5.21.1 Inspired Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 56

5.22 Jarvik Heart Inc Company Overview 57

5.22.1 Jarvik Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.23 LaunchPoint Technologies Inc Company Overview 62

5.23.1 LaunchPoint Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.24 Leviticus Cardio Ltd Company Overview 64

5.24.1 Leviticus Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

5.25 Levram Medical Systems Ltd Company Overview 66

5.25.1 Levram Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

5.26 Magenta Medical Inc Company Overview 67

5.26.1 Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.27 Mayo Clinic Company Overview 68

5.27.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 68

5.28 Medtronic Plc Company Overview 69

5.28.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 69

5.29 Nipro Corp Company Overview 70

5.29.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 70

5.30 OrbusNeich Company Overview 72

5.30.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 72

5.31 Percassist Inc Company Overview 73

5.31.1 Percassist Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.32 Perfusion Solution Inc Company Overview 74

5.32.1 Perfusion Solution Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.33 PlugMed Heart SAS Company Overview 75

5.33.1 PlugMed Heart SAS Pipeline Products & Ongoing Clinical Trials Overview 75

5.34 PulseCath BV Company Overview 76

5.34.1 PulseCath BV Pipeline Products & Ongoing Clinical Trials Overview 76

5.35 ReliantHeart, Inc. Company Overview 77

5.35.1 ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

5.36 Shenzhen Core Medical Technology Co Ltd Company Overview 79

5.36.1 Shenzhen Core Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

5.37 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 82

5.37.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 82

5.38 Sunshine Heart Company, Pty. Ltd. Company Overview 83

5.38.1 Sunshine Heart Company, Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 83

5.39 Syntach AB Company Overview 84

5.39.1 Syntach AB Pipeline Products & Ongoing Clinical Trials Overview 84

5.40 Thoratec LLC Company Overview 85

5.40.1 Thoratec LLC Pipeline Products & Ongoing Clinical Trials Overview 85

5.41 Tokyo Medical and Dental University Company Overview 86

5.41.1 Tokyo Medical and Dental University Pipeline Products & Ongoing Clinical Trials Overview 86

5.42 U.S. Stem Cell Inc Company Overview 87

5.42.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 87

5.43 University of Virginia Company Overview 88

5.43.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 88

5.44 VASCOR Inc Company Overview 89

5.44.1 VASCOR Inc Pipeline Products & Ongoing Clinical Trials Overview 89

5.45 Windmill Cardiovascular Systems, Inc. Company Overview 90

5.45.1 Windmill Cardiovascular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90

5.46 W-Z BIOTECH, LLC Company Overview 92

5.46.1 W-Z BIOTECH, LLC Pipeline Products & Ongoing Clinical Trials Overview 92

5.47 Yale University Company Overview 94

5.47.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 94

6 Left Ventricular Assist Devices- Recent Developments 95

6.1 Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip’s new CEO 95

6.2 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022 95

6.3 Nov 01, 2022: Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency, up 7% on a Reported Basis Year Over Year 95

6.4 Oct 27, 2022: Teleflex Reports Third Quarter Financial Results And Full Year Outlook 97

6.5 Oct 13, 2022: Teleflex Announces Third Quarter 2022 Earnings Conference Call Information 98

6.6 Sep 30, 2022: Natalie Caine named chief administrative officer at Mayo Clinic in Rochester 98

6.7 Sep 13, 2022: TCT 2022: Impella enables complete revascularization, improved quality of life and native heart recovery 98

6.8 Aug 04, 2022: ABIOMED Announces First Quarter Record Revenue of $277 Million, up 10% Year Over Year, up 12% in Constant Currency 100

6.9 Jul 14, 2022: Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification 102

6.10 Jun 07, 2022: Teleflex launches new arrow pressure injectable midline catheter in Europe, the Middle East and Africa region 103

6.11 May 02, 2022: Teleflex to Host Analyst & Investor Day on May 20, 2022 103

6.12 Apr 28, 2022: Teleflex Reports First Quarter Financial Results And Full Year Outlook 104

6.13 Apr 28, 2022: Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year 105

6.14 Apr 08, 2022: Abiomed Fourth Quarter Fiscal 2022 Earnings and Conference Call Notification 107

6.15 Mar 21, 2022: Abiomed to Host Investor Call on Impella ECP, the World’s Smallest Heart Pump at 9 French 107

6.16 Feb 24, 2022: Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results 107

6.17 Feb 08, 2022: Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare Conference 109

7 Appendix 110

7.1 Methodology 110

7.2 About GlobalData 113

7.3 Contact Us 113

7.4 Disclaimer 113

Table

Left Ventricular Assist Devices – Pipeline Products by Stage of Development 12

Left Ventricular Assist Devices – Pipeline Products by Territory 13

Left Ventricular Assist Devices – Pipeline Products by Regulatory Path 14

Left Ventricular Assist Devices – Pipeline Products by Estimated Approval Date 15

Left Ventricular Assist Devices – Ongoing Clinical Trials 16

Left Ventricular Assist Devices Companies – Pipeline Products by Stage of Development 17

Left Ventricular Assist Devices – Pipeline Products by Stage of Development 19

Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview 21

Fully Implantable Left Ventricular Assist System – Product Status 21

Fully Implantable Left Ventricular Assist System – Product Description 21

Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Impella BTR – Product Status 22

Impella BTR – Product Description 22

Impella ECP – Product Status 23

Impella ECP – Product Description 23

Next Generation Impella CP – STEMI – Product Status 23

Next Generation Impella CP – STEMI – Product Description 24

Abiomed Inc – Ongoing Clinical Trials Overview 25

Impella ECP – Use of the Impella ECP in Patients Undergoing an Elective High-risk Percutaneous Coronary Intervention: An Early Feasibility Study 26

Impella ECP – Use of the Impella ECP in Patients Undergoing an Elective or Urgent High-Risk Percutaneous Coronary Intervention 26

Next Generation Impella CP – STEMI – Primary Unloading and Delayed Reperfusion in St-elevation Myocardial Infarction: The STEMI-DTU Trial 27

Impella BTR – Use of the Impella BTR in Patients with Heart Failure: An Early Feasibility Study 28

APK Advanced Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

Apical Access System – Product Status 29

Apical Access System – Product Description 29

Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview 30

CorAide Left Ventricular Assist System – Product Status 30

CorAide Left Ventricular Assist System – Product Description 30

BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 31

PliCath HF – Product Status 31

PliCath HF – Product Description 31

Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

Calon MiniVAD – Product Status 32

Calon MiniVAD – Product Description 32

MicroVAD – Product Status 33

MicroVAD – Product Description 33

Cardiac Success Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

V-Sling Device – Product Status 34

V-Sling Device – Product Description 34

CardiacBooster BV Pipeline Products & Ongoing Clinical Trials Overview 35

Intra-Aortic Balloon Pump – Product Status 35

Intra-Aortic Balloon Pump – Product Description 35

CARDIAnove Inc Pipeline Products & Ongoing Clinical Trials Overview 36

CARDIAnove Pump – Product Status 36

CARDIAnove Pump – Product Description 36

Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 37

Non-Blood Contacting Muscle Powered VAD – Product Status 37

Non-Blood Contacting Muscle Powered VAD – Product Description 37

Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 38

PediPump – Product Status 38

PediPump – Product Description 38

Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 39

SmartHeart LVAD – Product Status 39

SmartHeart LVAD – Product Description 39

CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

CORolla – Product Status 40

CORolla – Product Description 40

CorAssist Cardiovascular Ltd – Ongoing Clinical Trials Overview 41

CORolla – CORolla TAA for Heart Failure with Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility 42

Corvion Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Nautilus Pump – Product Status 43

Nautilus Pump – Product Description 43

CorWave SA Pipeline Products & Ongoing Clinical Trials Overview 44

CorWave LVAD – Product Status 44

CorWave LVAD – Product Description 44

CorWave Nemo – Product Status 45

CorWave Nemo – Product Description 45

Duke University Pipeline Products & Ongoing Clinical Trials Overview 46

Para-Aortic Blood Pump – Product Status 46

Para-Aortic Blood Pump – Product Description 46

Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview 47

EVAHEART 2 Left Ventricular Assist System – Product Status 47

EVAHEART 2 Left Ventricular Assist System – Product Description 47

Evaheart Inc – Ongoing Clinical Trials Overview 48

EVAHEART 2 Left Ventricular Assist System – Prospective Multi-Center Randomized Study for Evaluating the EVAHEART2 Left Ventricular Assist System: the COMPETENCE Trial 49

FineHeart Pipeline Products & Ongoing Clinical Trials Overview 50

ICOMS FLOWMAKER – Product Status 50

ICOMS FLOWMAKER – Product Description 50

HeartWare International Inc Pipeline Products & Ongoing Clinical Trials Overview 51

HVAD System – Destination Therapy – Product Status 51

HVAD System – Destination Therapy – Product Description 52

Levacor Rotary VAD – Product Status 52

Levacor Rotary VAD – Product Description 52

Longhorn – Product Status 53

Longhorn – Product Description 53

Miniaturized Ventricular Assist Device (MVAD) Pump – Product Status 53

Miniaturized Ventricular Assist Device (MVAD) Pump – Product Description 54

VCAN Trans-Mitral – Product Status 54

VCAN Trans-Mitral – Product Description 54

Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview 55

Left Ventricular Assist Device – Product Status 55

Left Ventricular Assist Device – Product Description 55

Inspired Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 56

Neomate System – Product Status 56

Neomate System – Product Description 56

Jarvik Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Jarvik 2000 Heart – Bridge To Transplant – Product Status 57

Jarvik 2000 Heart – Bridge To Transplant – Product Description 57

Jarvik 2000 Heart – Destination Therapy – Product Status 58

Jarvik 2000 Heart – Destination Therapy – Product Description 58

Jarvik 2015 – Product Status 58

Jarvik 2015 – Product Description 59

Jarvik Heart Inc – Ongoing Clinical Trials Overview 60

Jarvik 2015 – Pumps for Kids, Infants, and Neonates 61

LaunchPoint Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 62

Pediaflow Pediatric VAD – Product Status 62

Pediaflow Pediatric VAD – Product Description 62

Streamliner VAD – Product Status 63

Streamliner VAD – Product Description 63

Leviticus Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

FiVAD System – Product Status 64

FiVAD System – Product Description 64

Hybrid FILVAS – Product Status 65

Hybrid FILVAS – Product Description 65

Levram Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

Levram – Ventricular Assist Device – Product Status 66

Levram – Ventricular Assist Device – Product Description 66

Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Magenta pLVAD – Product Status 67

Magenta pLVAD – Product Description 67

Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 68

Implantable Left Ventricular Assist Device – Product Status 68

Implantable Left Ventricular Assist Device – Product Description 68

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 69

Fully Implantable Left Ventricular Assist Device – Product Status 69

Fully Implantable Left Ventricular Assist Device – Product Description 69

Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 70

BR16010 – Product Status 70

BR16010 – Product Description 70

Implantable Left Ventricular Assist Device – Product Status 71

Implantable Left Ventricular Assist Device – Product Description 71

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 72

ECMO Left Ventricular Assist Device – Product Status 72

ECMO Left Ventricular Assist Device – Product Description 72

Percassist Inc Pipeline Products & Ongoing Clinical Trials Overview 73

PercAssist Ventricular Assist Device – Product Status 73

PercAssist Ventricular Assist Device – Product Description 73

Perfusion Solution Inc Pipeline Products & Ongoing Clinical Trials Overview 74

Transapical LVAD – Product Status 74

Transapical LVAD – Product Description 74

PlugMed Heart SAS Pipeline Products & Ongoing Clinical Trials Overview 75

Implantable Left Ventricular Assist Device – Product Status 75

Implantable Left Ventricular Assist Device – Product Description 75

PulseCath BV Pipeline Products & Ongoing Clinical Trials Overview 76

iVAC 2L – Product Status 76

iVAC 2L – Product Description 76

ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

aVAD Liberty System – Product Status 77

aVAD Liberty System – Product Description 77

VAD Maintenance System – Product Status 78

VAD Maintenance System – Product Description 78

Shenzhen Core Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

Corheart 6 Left Ventricular Assist System – Product Status 79

Corheart 6 Left Ventricular Assist System – Product Description 79

Shenzhen Core Medical Technology Co Ltd – Ongoing Clinical Trials Overview 80

Corheart 6 Left Ventricular Assist System – Corheart 6 Left Ventricular Assist System Prospective, Multicenter, Single-arm Clinical Evaluation Trial 81

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 82

Paracorporeal Left Ventricle Assist Device – Product Status 82

Paracorporeal Left Ventricle Assist Device – Product Description 82

Sunshine Heart Company, Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 83

C-Pulse – Wireless Version – Product Status 83

C-Pulse – Wireless Version – Product Description 83

Syntach AB Pipeline Products & Ongoing Clinical Trials Overview 84

Syntach CS – Product Status 84

Syntach CS – Product Description 84

Thoratec LLC Pipeline Products & Ongoing Clinical Trials Overview 85

DuraHeart II – Product Status 85

DuraHeart II – Product Description 85

Tokyo Medical and Dental University Pipeline Products & Ongoing Clinical Trials Overview 86

TinyPump – Product Status 86

TinyPump – Product Description 86

U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 87

SVAD – Product Status 87

SVAD – Product Description 87

University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 88

VADStent – Product Status 88

VADStent – Product Description 88

VASCOR Inc Pipeline Products & Ongoing Clinical Trials Overview 89

Vascor LVAD – Product Status 89

Vascor LVAD – Product Description 89

Windmill Cardiovascular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90

Pediatric TORVAD – Product Status 90

Pediatric TORVAD – Product Description 90

TORVAD – Product Status 91

TORVAD – Product Description 91

W-Z BIOTECH, LLC Pipeline Products & Ongoing Clinical Trials Overview 92

Double Lumen Cannula-Based Left Ventricular Assist Device – Product Status 92

Double Lumen Cannula-Based Left Ventricular Assist Device – Product Description 92

SppVAD – Product Status 93

SppVAD – Product Description 93

Yale University Pipeline Products & Ongoing Clinical Trials Overview 94

BoLetz Pump – Product Status 94

BoLetz Pump – Product Description 94

Glossary 112

Figures

Left Ventricular Assist Devices – Pipeline Products by Stage of Development 12

Left Ventricular Assist Devices – Pipeline Products by Territory 13

Left Ventricular Assist Devices – Pipeline Products by Regulatory Path 14

Left Ventricular Assist Devices – Pipeline Products by Estimated Approval Date 15

Left Ventricular Assist Devices – Ongoing Clinical Trials 16

Frequently asked questions

Left Ventricular Assist Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Left Ventricular Assist Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Left Ventricular Assist Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Left Ventricular Assist Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.